Dr. Tomohiro Chiba (male; pathologist, molecular biologist, neuropharmacologist) received his medical doctor degree (M.D., 2001) and philosophical doctor degree (Ph.D., 2005) from KEIO University, School of Medicine (Tokyo, Japan). He worked at Georg-Speyer-Haus, Institute for Biomedical Researches (Frankfurt am Main, Germany, 2010-2012) on a research fellowship for experienced researchers granted by the Alexander von Humboldt Foundation. Currently, he is working as an Assistant Professor at Kyorin University School of Medicine. He has been focusing on Intracellular signaling pathways, especially the Janus kinase (Jak)/signal transducer and activator of transcription (Stat) pathway, in cancer cells and their microenvironment.
Breast cancer; Glioma/glioblastoma; Thyroid cancer and gastric cancer; Cancer Biology; Clinical pathology; Molecular Biology; Pharmacology; Signal transduction; Cell death; Invasion and metastasis; Cancer stem cells; Epithelial-mesenchymal transition (EMT); Tumor microenvironment.